BRAMBILLA, GIANMARIA
 Distribuzione geografica
Continente #
NA - Nord America 4.235
AS - Asia 2.139
EU - Europa 1.742
SA - Sud America 322
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 8.508
Nazione #
US - Stati Uniti d'America 4.035
SG - Singapore 827
CN - Cina 439
DE - Germania 341
VN - Vietnam 283
RU - Federazione Russa 271
HK - Hong Kong 262
SE - Svezia 260
BR - Brasile 232
IE - Irlanda 205
CA - Canada 173
UA - Ucraina 163
IT - Italia 153
FR - Francia 108
GB - Regno Unito 98
IN - India 78
BD - Bangladesh 53
FI - Finlandia 53
AR - Argentina 32
KR - Corea 26
TR - Turchia 26
IQ - Iraq 24
BE - Belgio 19
JP - Giappone 17
PL - Polonia 16
NL - Olanda 15
ZA - Sudafrica 15
MX - Messico 13
PK - Pakistan 13
CO - Colombia 12
ES - Italia 12
CL - Cile 11
EC - Ecuador 11
ID - Indonesia 10
VE - Venezuela 10
PH - Filippine 9
SA - Arabia Saudita 9
EG - Egitto 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
MA - Marocco 7
UZ - Uzbekistan 7
ET - Etiopia 6
EU - Europa 6
LB - Libano 6
KE - Kenya 5
KZ - Kazakistan 5
TH - Thailandia 5
AT - Austria 4
AZ - Azerbaigian 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
NP - Nepal 4
RO - Romania 4
AU - Australia 3
BG - Bulgaria 3
BJ - Benin 3
DZ - Algeria 3
OM - Oman 3
PE - Perù 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
HN - Honduras 2
KH - Cambogia 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.508
Città #
Singapore 468
Ashburn 394
Woodbridge 365
Ann Arbor 351
Fairfield 273
Chandler 255
Hong Kong 255
Houston 254
San Jose 237
Frankfurt am Main 217
Dublin 196
Jacksonville 174
Seattle 129
New York 117
Dearborn 116
Cambridge 112
Toronto 110
Wilmington 108
Hanoi 79
Ho Chi Minh City 78
Princeton 74
Beijing 72
Los Angeles 69
Santa Clara 66
Chicago 64
Nanjing 50
The Dalles 42
Lauterbourg 37
Dallas 34
Milan 34
Lachine 33
Lawrence 32
Altamura 30
Seoul 25
Shanghai 25
Buffalo 24
Moscow 24
São Paulo 24
Hefei 22
Munich 20
Brussels 17
Nanchang 17
Orem 17
Shenyang 16
Tianjin 16
Hebei 15
Ottawa 14
San Diego 14
Belo Horizonte 13
Helsinki 13
Tokyo 12
Baghdad 11
Chennai 11
Council Bluffs 11
Warsaw 11
Andover 10
Düsseldorf 10
Fremont 10
Guangzhou 10
Haiphong 10
Changsha 9
Da Nang 9
Hangzhou 9
London 9
Lissone 8
Zhengzhou 8
Montreal 7
Ningbo 7
Rio de Janeiro 7
Rome 7
Turku 7
Addis Ababa 6
Boardman 6
Caracas 6
Columbus 6
Denver 6
Dhaka 6
Guayaquil 6
Jinan 6
Medellín 6
Norwalk 6
Porto Alegre 6
Salt Lake City 6
Santiago 6
Stockholm 6
Tampa 6
Boston 5
Cairo 5
Jiaxing 5
Johannesburg 5
Phoenix 5
Pune 5
Atlanta 4
Bexley 4
Brno 4
Brooklyn 4
Chandigarh 4
Detroit 4
Dong Ket 4
Lancaster 4
Totale 5.586
Nome #
The Pamela study: main findings and perspectives 304
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 297
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 297
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 285
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 285
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension 277
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 276
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 270
New-onset left atrial enlargement in a general population 265
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 265
Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity 263
Role of ambulatory blood pressure monitoring in resistant hypertension 259
Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study 255
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 240
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 238
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 231
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 230
Differential patterns of regional neuroadrenergic cardiovascular drive in acromegalic disease 229
Targets for body fat, blood pressure, lipids, and glucose-lowering interventions in healthy older people 228
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 226
Failure of monolateral renal nerve ablation to exert sympathoinhibitory and blood pressure lowering effects in a patient with resistant hypertension: a case report 225
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 223
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 223
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 215
Reduced Insulin Sensitivity is Associated with Adrenergic Overdrive Independently on Obesity and Hypertension 215
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 214
Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension 199
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 197
The role of carotid baroreceptor stimulation 194
Effects of Renal Denervation on Sympathetic Nervous System Activity 193
The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation 192
Reduced insulin sensitivity is associated with adrenergic overdrive in hemochromatosis independently on obesity and hypertension 192
Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: A time-integrated analysis 191
Dissociation between the behaviour of arterial stiffness and muscel sympathetic nerve traffic in patients with htart failure treated with chronic baroreflex activation 160
Prevalence and main features of resistant hypertension in central and eastern Europe: the BP-CARE Study 152
CPAP in acute pulmonary edema. Our experience of the nurse role in the out of hospital life support 145
Metabolic profile and control by treatment and relationships with blood pressure values in patients from central and easter European countries: the BP-CARE metaboli study 136
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population 134
Totale 8.620
Categoria #
all - tutte 28.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.321


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 0 0 0 0 0 0 0 0 26 50
2021/2022396 9 36 39 39 35 27 12 25 20 39 38 77
2022/2023882 92 327 70 82 33 144 3 62 54 3 9 3
2023/2024576 12 20 25 46 73 149 130 24 37 4 3 53
2024/20251.235 66 165 59 50 117 18 40 64 171 190 108 187
2025/20262.804 330 126 223 293 403 140 415 124 265 336 149 0
Totale 8.620